{"nct_id":"NCT06555796","title":"Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-09-23","start_date_type":"ACTUAL","primary_completion_date":"2026-12-21","primary_completion_date_type":"ESTIMATED","completion_date":"2029-06-21","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AMGN"]}